MEDICAL AFFAIRS: The Roles, Value and Practice of Medical Affairs in the Biopharmaceutical and Medical Technology Industries (Taylor & Francis, 2024)
MAPS is excited to announce publication of the MAPS Medical Affairs Competency Framework, detailing 42 competencies across 7 domains identified as essential to the success of Medical Affairs professionals.
“I see Medical Affairs co-leading the pharmaceutical and MedTech industries into a new era of patient-centered evidence generation and communication in a valued-based world,” Kremer says.
Kesselring will work with the MAPS Professional Development Committee to assist with the creation of courses supporting 7 Medical Affairs competency certification tracks identified in the MAPS 5-year strategic plan.
MAPS announces the election of Dr. Danie du Plessis as Chair of the MAPS Board of Directors. Du Plessis is currently Executive Vice-President (EVP) & Head of Medical Affairs at Kyowa Kirin International and is a senior pharmaceutical executive with 30 years’ experience.
From space biology to patient voice to best practices for onboarding, here are highlights of the APPA/MAPS Joint Medical Affairs Summit in Sydney, Australia.
At the MAPS 2022 Global Annual Meeting in New Orleans, we sat down with Medical Affairs leaders in attendance to discuss a range of issues important to the function. Now as we prepare for the MAPS 2023 Global Annual Meeting in Nashville, March 26-29 (early bird registration open until December 31!), join us in looking back at these important opinions. Have a topic you’d like covered at the 2023 meeting? Email MAPS Communications/Marketing Director, Garth Sundem, with your suggestions!
The Medical Affairs Professional Society (MAPS) is honored to announce the appointment of Charlotte Kremer, MD, MBA as the organization’s Chief Strategy Officer in a volunteer capacity, next to her volunteer role as Chair of the Board of Directors.
The Medical Affairs Professional Society (MAPS) and the Industry Pharmacists Organization (IPhO) are pleased to announce an important new strategic collaboration to help advance the careers of student pharmacists interested in the pharmaceutical industry, as well as Fellows and early-stage Industry Pharmacist professionals.
MAPS is honored to announce the appointment of William (Bill) Sigmund, MD, MHS, EVP and Chief Medical Officer at Becton Dickinson, to the MAPS Board of Directors.